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Prioritizing a sequence of short-duration groups as
the standardized pathway for chronic noncancer
pain at an Australian tertiary multidisciplinary pain
service: preliminary outcomes
Hema Rajappaa,*, Michelle Wilsona, Ruth Whitea, Megan Blanchardb, Hilarie Tardifb, Chris Hayesa
Abstract
Objective: To describe implementation and report preliminary outcomes of a resource-efficient, standardized group pathway for
chronic noncancer pain.
Design: Descriptive cross-sectional study of a group-based pain management pathway in comparison with an Australasian
benchmarking data set.
Setting: An Australian tertiary multidisciplinary pain service.
Subjects: Patients with chronic noncancer pain actively participating in the group pathway in 2016.
Methods: Referred patients were prioritized to a short-duration group–based standardized pain management pathway linking
education, assessment, and treatment groups. Measures of pain, mood, self-efficacy, and catastrophizing and reduction in daily
opioid use were collated from the Australasian data set.
Results: In 2016, 928 patients were actively engaged with the pain service. More patients were prioritized to receive treatment in
a group format in comparison with other Australasian services (68.4% vs 22%). A greater percentage of patients attended their first
clinical contact within 3 months of referral (81.4%) compared with the Australasian average (68.6%). Comparable improvements in
average pain intensity, pain interference, depression, anxiety, stress, pain catastrophizing, and self-efficacy were observed. There
was significantly greater reduction in opioid use, including for those taking more than 40 mg of oral morphine equivalent daily dose.
Conclusion: Implementation of a sequence of short-duration groups as the default clinical pathway resulted in shorter waiting times
and noninferior outcomes in key areas for patients completing the program, compared with Australasian averages. Given the
resource efficiencies of the group process, this finding has implications for service design.
Keywords: Group process, Pain management, Model of care, Persistent pain
1. Introduction
The complexity and prevalence of chronic noncancer pain
challenges existing models of service delivery. More than 80%
of people experiencing chronic noncancer pain do not receive
timely pain treatment, and this brings an associated risk of
deterioration while waiting.26,40,47The number of people with
chronic noncancer pain in Australia is predicted to increase
from 3.24 million in 2018 to 5.23 million in 2050.16 Current
health care systems struggle to contain the costs of chronic
pain, estimated at more than 200 billion Euros in Europe, 150
billion dollars in the United States, and 73.2 billion dollars in
Australia per annum.16,57
At public hospital tertiary pain centers in Australia, the
traditional model of care has incorporated individual multi-
disciplinary assessment, followed by individual pain special-
ist led treatment as the usual pathway, with only select
patients entering group treatment programs of varying
duration.
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The need for service redesign has been recognized worldwide,
and various innovations trialed.9,13,22,29,35,36,55 The implementa-
tion of short preassessment education group sessions has led to
reduction in wait times, early exposure to evidence-informed pain
management, and patient familiarization with group-based
treatment.6,12,24 Adaptations of this intervention are now
commonplace in Australian public hospital pain services. The
development of a group-based format for pain assessment with
further efficiencies in resource utilization and patient flow was an
additional innovation at Hunter Integrated Pain Service (HIPS).50
The group assessment showed resource efficiency in reducing
wait times by providing clinicians with the capacity to manage
multiple patients simultaneously, and by reducing the impact of
patient nonattendance compared with the individual format.
Based on this preliminary work, HIPS embarked on creating
a resource-efficient, standardized management pathway that
was entirely group-based, linking preassessment education,
assessment, and treatment groups.
The content of all groups, from initial education to assessment
to active treatment, emphasizes a whole person approach and
the implementation of active self-management, rather than
passively received treatment strategies.24,39,60 This aims to
modify brain interpretation, wind down nervous system sensiti-
zation, and reduce pain intensity over time.
This study aims to describe the implementation of a standard-
ized group pathway in terms of content and process. Preliminary
outcome data are reported.
2. Methods
2.1. Subjects
Patients included in this cross-sectional study are those adults with
chronic noncancer pain who participated in the standardized group
pathway in 2016 (January 1, 2016–December 31, 2016), after referral
to HIPS. Owing to the continuous nature of patient flow through the
service, there were patients active in the pathway in 2016, whose
initial engagement occurred the previous year. On the other hand,
some patients referred during 2016 did not become active in the
pathwayuntil the following year andsowerenot included in the study.
In carefully selected cases, individual assessment and treatment
was offered as a nonstandard option. This included those whowere
cognitively impaired, elderly (.75 years), severely disabled (eg,
quadriplegic), or those identified in the referral as not appropriate for
group participation (eg, deaf, blind, or non-English speaking).
Patients initially participating in individual treatment could choose
to enter the standardized group pathway. Requests from patients in
the group pathway to switch to the individual pathway were
considered on a case-by-case basis, in view of patient factors such
as reports of excessive anxiety in group situations, previously
unidentified visual or hearing impairments, or language barriers. The
individual pathway outcomes are not reported in this study.
2.2. Data collection processes
The implementation of an Australasian chronic pain database,
electronic Persistent Pain Outcomes Collaboration (ePPOC), has
been reportedpreviously.54 Study datawere primarily drawn from the
2016 ePPOC HIPS annual report. The ePPOC team based at the
University of Wollongong collates nonidentifiable patient data sub-
mitted electronically by participating pain services across Australia
and New Zealand. These data are then analyzed and provided to
eachservice inmidyear andannual reports. In 2016, ePPOC included
data from 46 specialist pain services in Australia and New Zealand.
2.3. Questionnaires
Patients are requested to complete the ePPOC entry questionnaire
after referral, and this is collected at their first appointment. The
questionnaire includes demographic and baseline data for a battery
of standardized assessment tools: Brief Pain Inventory, Depression,
Anxiety, and Stress Scale (DASS21), Pain Catastrophizing Scale
(PCS), and Pain Self-Efficacy Questionnaire (PSEQ).32,38,43,52,53 A
brief description of each tool, interpretation of scores, and criteria to
determine clinical significance of change in scores is provided in
Appendix 1 (available as Supplemental digital content at http://links.
lww.com/PR9/A49).18 Patients also received an ePPOC review
questionnaire at completionof active treatment andat 3monthsafter
their last clinical interaction with the service.
2.4. Statistics
Data were extracted from the ePPOC database into text files,
then imported into SAS (version 9.4; SAS Institute, NC), to be
statistically analyzed. This included comparison of clinically
significant improvement on each assessment tool from referral
to end of active treatment, for HIPS and other services. Reduction
in daily opioid use and waiting times from referral to first contact
Figure 1. Hunter Integrated Pain Service standardized group pathway.
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were also compared. For both HIPS and other services, “n” varied
depending on whether the questionnaire was returned and if an
itemwas completed or if missing, imputable. For categorical data,
the x2 test was used to test for difference in proportions. For
continuous data, the t test was used to test for difference in mean
values. P values less than 0.05 were considered statistically
significant.
2.5. Missing data
Patients needed to complete a required number of items in the
assessment tools for a subscale to be considered valid, with
missing items imputed as the average of completed items for the
DASS, PCS, and PSEQ subscales (see Appendix 1, available as
Supplemental digital content at http://links.lww.com/PR9/A49).
2.6. Ethical approval and consent
Only patients who consented to their data being used for
research purposes in the ePPOC entry and review questionnaires
were included in this study.
Ethical approval to establish ePPOC and use the deidentified
Australian data set for reporting and research purposes has been
obtained through the Ethics Committee at University of
Wollongong.
2.7. Overview of the group process
The standardized group pathway consisted of 3 sequential steps
(Fig. 1). The first step was the education group titled, “Un-
derstanding Pain.” This was followed by the second step, which
was a group assessment termed, “Assessment and Planning.”
The third step was the core treatment group named, “Active Pain
Treatment.” Patients were given the option of bringing a support
person or carer to the first 2 steps. Patients followed this
sequence of steps progressing through the pathway, but could
exit at any step, resulting in treatment recommendations being
sent to their referrer or general practitioner (GP). After completion
of the group pathway, patients could choose further review with
the service. The review and subsequent patient outcomes are
beyond the scope of this article.
At each step of the pathway, there was an emphasis on
expanding and reinforcing key messages from the previous step
with supportive interactions between clinicians and patients.
Appropriate and effective communication techniques were used,
including empathy, validation, and motivational interviewing.1,7,19
An environment conducive to behavior change was created and
fostered.15,19
Content of each group reflected current evidence and the
requirement to target low health literacy.28,31,45,46,49,59 Cognitive
and behavior change targets were identified in a collaborative
fashion. At each step, clinicians and patients worked in partner-
ship, towards identification and development of realistic and
meaningful targets. These targets included reducing opioids,
catastrophizing and pain interference, and increasing physical
activity and pain self-efficacy. Patients had an active role in
modifying and fine-tuning targets through their journey with the
service.
Table 1 summarizes the details of each group of the
standardized pathway.
2.8. Understanding Pain
After referral and triaging, most patients were invited to the first
step in the standardized group pathway, Understanding Pain,
which has been reported previously.24 This preassessment
education group ran in the form of an interactive seminar with
multimedia presentation and opportunities for questions and
comments. Content emphasized current pain neuroscience,
neuroplasticity, a whole person approach and the transition from
passively received medical treatments to active self-treatment.
The content was available in digital format for ease of access to
remotely situated patients.27
For those who chose to progress beyond Understanding Pain,
a secondary triage process occurred. This was based on any new
information contained in the ePPOC referral questionnaire
(routinely collected at Understanding Pain) or obtained through
direct observation of or conversation with the patient at Un-
derstanding Pain. Most patients were invited to attend the next
step in the group pathway, a multidisciplinary group pain
assessment workshop titled “Assessment and Planning.”
2.9. Assessment and Planning
The resource requirements and content of this workshop have
been reported in detail previously.50 Throughout the day,
patients were guided to perform their own structured self-
assessment and developed a personalized pain recovery plan
(Appendix 2, available as Supplemental digital content at http://
links.lww.com/PR9/A49). The workshop was interactive and
had an emphasis on expanding and reinforcing key messages
from Understanding Pain, with supportive interactions between
Table 1
Overview of groups.
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clinicians and patients. Patients also received a manual
summarizing the content of the workshop and had the
opportunity to collect printed information on topics such as
pain-related medication and accessing community psychology
services.
Patients identified as takingmore than 100mgof oral morphine
equivalent daily dose or taking medications associated with
significant health risks were offered a brief individual medication
review with the specialist pain medicine physician. The patient’s
prescription medication was discussed, and a medication plan,
which may have included a deprescribing regimen, was
negotiated with the patient’s active participation. A copy of the
pain recovery plan, team report, and medication plan (if
applicable) was forwarded to the referrer.
2.10. Active Pain Treatment
The final step in the standardized group pathway was attendance
at a core treatment group called “Active Pain Treatment,” with
a duration of 21 hours over 6 weeks.
This 6-week group program, conducted 1 day every week, was
facilitated by a clinical psychologist, a pain physiotherapist, and
a clinical nurse specialist. The core treatment program reinforced
a whole person approach, addressing 5 domains of pain
management: biomedical, mindbody, connection, activity, and
nutrition.25 Implementation of active self-management,with reduced
reliance on passive strategies including pain-related medications,
was encouraged.41 The Explain Painmodel was used to discuss the
neuroscience of chronic pain.39 Psychological elements of this
program were mainly based on cognitive behavioural therapy with
inclusion of mindfulness-based strategies.20,48,56 Components
included reframing of dysfunctional cognitions, enabling adaptive
behaviors andgraded task assignments to enhance functioning. The
contribution of social disconnection to pain experience in partic-
ipants and ways to re-establish connection to people, purpose,
and place was explored.51Gradual grading up of physical activities
from baseline, incorporating pacing strategies, and mindful
movement were important components of the physical activity
domain of pain management.23,42 Participants were also invited to
review their diet and anthropometric measures andmake healthier
food choices to improve overall wellbeing.3,4
A brief outline of the program, including the primary behavioral
targets, is outlined in Table 2. Patients were given simple written
resources on active treatment strategies developed and updated
regularly in line with current evidence regarding pain.
The clinical nurse specialist facilitated sessions on pain-related
medications and nutrition. Options of further medication input, in
person or over the phone, with the clinical nurse specialist were
also offered. Another alternative offeredwas a phone consultation
between the specialist pain medicine physician and the GP.
The importance of regular weekly attendance was empha-
sized, and limited catch-up options were available for missed
sessions. On the final week of the Active Pain Treatment group,
patients reviewed and updated their pain recovery plan created at
Assessment and Planning.
2.11. Patient–clinician phone interactions
For all groups except Understanding Pain, patients received
a preparatory phone call. A staff member checked on patient
readiness to attend, current pain medications and answered any
questions regarding the group.
After referral, at any step, patients were able to phone for
support during working hours. This support included reviewing
progress and discussing challenges, including those related to
medication deprescribing.
Table 2
Outline of Active Pain Treatment Program (APT).
Week Content summary
(# 5 practical sessions)
Primary behavioral target/s
1 Introduction ↑ Valued physical/functional activity
Goal setting ↑ Daily walk time/speed of walking
Physical self-assessment ↓ Opioid use/dose
Baseline activity level ↓ Opioid/other medication use related to
chronic noncancer pain
Daily walk





2 Review of home tasks ↑ Daily walk time/speed of walking
Pain beliefs ↑ Minutes engaged in moderate physical
activity
12-min walk# ↑ Use of helpful/positive self-talk





3 Review of home tasks ↑ Daily movement
Mindful movement# ↑ Daily use of sleep skills/optimise sleep
Pain science ↑ Use of daily relaxation response skills
Sleep ↑ Use of nonreactive communication skills
Relaxation# ↑ Daily walk time/speed of walking





4 Review of home tasks ↑ Daily utilisation of relaxation response
Relaxation# ↑ Use of movement/relaxation in all
contexts, eg, flare-up
Pain science ↑ Leg strength through graded exposure






5 12-min walk# ↑ Daily walk time/speed of walking
Review of habit formation ↑ Daily helpful/“approach” habits
Timeline links ↑ Psychological capability/resilience
Stress load ↑ Use of optimal sleep skills, eg, sleep
restriction if insomnia present
Your story ↑ Fruit and vegetable intake
Sleep ↑ Function through new activity, eg,
mindful yoga





6 12-min walk# ↑ Daily walk time/speed of walking
Review of habit formation ↑ Daily helpful/“approach” habits
Relaxation# ↑ Daily relaxation response
Physical reassess ↑ New activities with pain, eg, mindful
yoga
Yoga# ↑ Planned approach to pain and goal
directed behavior
Update pain recovery plan
Goal setting
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2.12. Staff resource requirements for group interventions
Theclinical staff facilitating groups consistedof amix of specialist pain
medicine physicians, pain medicine trainees, clinical nurse special-
ists, clinical psychologists, and pain physiotherapists. Table 3 details
the entire 2016 staffing levels at HIPS, whereas Table 1 includes
details of staffing for each step of the group pathway.
3. Results
3.1. Patient flow through the service
In 2016, 928 patients were actively engaged with HIPS,
compared with 15,862 for other services (Table 4). During the
same period, HIPS received 1192 patient referrals. The number of
patients going through various steps in the group pathway in the
same period was 690, 278, and 92 patients for steps 1, 2, and 3,
respectively. As previously explained, this was not a cohort due to
the continuous nature of patient flow through the service.
Approximately 68.4% of HIPS patients were seen solely
through the group format, as compared to 22% of those
attending groups with other services. A higher percentage of
HIPS patients attended their first clinical contact within 3
months of referral compared with other services (81.4% vs
68.6%, P , 0.001).
3.2. Demographics of patient population
The 2016 ePPOC data showed HIPS patients at referral had
a similar patient profile to other services with some important
differences, which were clinically and statistically significant
(Table 4). More patients attending HIPS identified as being
indigenous, needed assistance with communication, took
opioids more than twice a week, and had experienced pain for
more than 5 years. Hunter Integrated Pain Service patients had
a higher proportion of patients who were unemployed due to
pain. The average number of associated comorbidities was
higher in the HIPS population, and although this difference was
statistically significant, it is unlikely to be clinically significant. Only
0.2% of HIPS patients required an interpreter compared with
5.4% for other services. Baseline characteristics including sex,
average age, opioid dose, number of drug groups used, and
number of sites of pain were similar in both populations.
3.3. Standardized assessment tools at referral
When comparing results from standardized assessment tools at
referral, average pain severity was lower in HIPS compared with
other services, and this was statistically significant, although
unlikely to be clinically significant (6.2 vs 6.4). There was no
statistically significant difference between HIPS patients and
those attending other services with regards to the other
assessment tools (Table 5).
3.4. Patient outcomes
In those patients who scored in the moderate/severe/extremely
severe categories of standardized assessment tools (Brief Pain
Inventory, DASS21, PCS, and PSEQ) at referral, there were no
statistically significant differences in the proportion of patients
making clinically significant improvement over time betweenHIPS
and other services (Table 6).
A higher proportion of HIPS patients achieved a 50% or greater
than 50% reduction in opioid use at end of treatment compared with
other services. Thedifference inproportionswasstatistically significant
for all patients onopioids aswell as the subgroupof patients on 40mg
or more oral morphine equivalent daily dose at referral.
Table 3
Staffing at HIPS.
Position Full time equivalent (FTE)
(1 FTE 5 40 hours per week)
Specialist pain medicine physicians 1.6
Pain medicine trainee fellows 1.0





HIPS, Hunter Integrated Pain Service.
Table 4
Patient demographics at referral.
Demographic information at referral
HIPS (n) Other services (n) P
Gender (female) 58.5% (928) 58.4% (15862) 0.942
Average age (y) 51.3 (928) 51.1 (15862) 0.780
Interpreter required 0.2% (914) 5.6% (14995) ,0.001
Communication assistance required 12.2% (920) 9.4% (14510) 0.003
Indigenous status 8.3% (885) 3.8% (13195) ,0.001
Average number of pain sites 4.0 (923) 3.9 (14465) 0.131
Average number of comorbidities 2.5 (767) 2.3 (11648) ,0.001
Opioid use .2 d/wk 66.4% 58.3% ,0.001
Average daily morphine equivalent (mg)* 71.3 (373) 70.3 (5071) 0.830
Average number of drug groups used 2.6 (544) 2.6 (8406) 0.984
Unemployment due to pain 39.7% (552) 33.5% (10763) 0.003
Experiencing pain .5 y 51.1% (849) 43.5% (14178) ,0.001
* For those patients taking opioids.
HIPS, Hunter Integrated Pain Service.
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4. Discussion
The standardized group pathway aims for the best possible
patient outcomes while maximizing efficient utilization of finite
staff resources.
Population profile was similar at baseline between HIPS and
other services, except for some differing vulnerabilities in theHIPS
population (higher indigenous status and communication
difficulties and lower need for interpreter). Despite this, clinical
outcomes were noninferior, and there were lower wait times. It
was also noted that greater opioid reduction was achieved.
Utilization of the HIPS group pathway facilitates exposure of an
increased number of patients to group intervention. There is
a theoretical risk of poorer pathway outcomes from using group
education and assessment, as opposed to individual (due to
dilution of personal contact time and reduced emphasis on
individual patient selection). However, this study affirms that it is
possible to achieve noninferior patient-related outcomes as
compared to other services, while facilitating increased numbers
of patients through a standardized, short-duration group
pathway.
An early invite to the initial large group, Understanding Pain,
offers a timely and potentially therapeutic interaction to a high
number of patients and their support persons. It minimizes
waiting times, introduces patients to a group setting, and allows
for the option of an early discharge.12,24
Undertaking assessment in a short-duration group workshop,
the second step in the standardized group pathway, is resource-
efficient as it can be overbooked, unlike individual assess-
ment.14,50,61 This helps to counter the problem of patient
nonattendance, which is well known in most chronic conditions,
Table 5
Patient assessment tool scores at referral.
Assessment tool scores at referral
Domain HIPS (n) Other services (n) P
Pain severity 6.2 (530) 6.4 (10673) 0.0384
Pain interference 7.1 (571) 7.0 (10946) 0.3868
Depression 19.8 (553) 20.2 (10685) 0.5660
Anxiety 13.7 (529) 14.1 (10651) 0.4104
Stress 20.8 (549) 21.0 (10621) 0.7473
Pain catastrophizing 28.6 (546) 29.4 (10550) 0.1859
Pain self-efficacy 21.9 (556) 20.8 (10732) 0.0543
HIPS, Hunter Integrated Pain Service.
Table 6
Patient outcomes measured by change in assessment tool scores and opioid use.
Outcome measures HIPS Other services P
BPI average pain 29.09% (n 5 55) 24.96% (n 5 1354) 0.4890
Patients with moderate or severe average
pain at referral making clinically significant
improvement at end of treatment
BPI pain interference 59.70% (n 5 67) 56.83% (n 5 1450) 0.6423
Patients with moderate or severe pain
interference at referral making clinically
significant improvement at end of
treatment
DASS21 depression 56.25% (n 5 48) 50.24% (n 5 1041) 0.4155
Patients with moderate, severe, or extremely
severe depression at referral making
clinically significant improvement at end of
treatment
DASS21 anxiety 36.59% (n 5 41) 39.44% (n 5 928) 0.7142
Patients with moderate, severe, or extremely
severe anxiety at referral making clinically
significant improvement at end of
treatment
DASS21 stress 50.00% (n 5 42) 52.15% (n 5 884) 0.7853
Patients with moderate, severe, or extremely
severe stress at referral making clinically
significant improvement at end of
treatment
PCS total 62.75% (n 5 51) 52.64% (n 5 1136) 0.1572
Patients with high or severe pain
catastrophizing at referral making clinically
significant improvement at end of
treatment
PSEQ total 54.72% (n 5 53) 47.66% (n 5 1284) 0.3138
Patients with moderate or severe pain
interference at referral making clinically
significant improvement at end of
treatment
oMEDD reduced by 50% or more for all patients
taking opioid medication at referral
65.96% (n 5 47) 45.59% (n 5 669) 0.0068
oMEDD reduced by 50% or more for patients
taking 40 mg 1 opioid medication at referral
61.29% (n 5 31) 39.57% (n 5 326) 0.0190
BPI, Brief Pain Inventory; oMEDD, oral morphine equivalent daily dose; HIPS, HIPS, Hunter Integrated Pain Service; PCS, Pain Catastrophizing Scale; PSEQ, Pain Self-Efficacy Questionnaire.
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including pain.21,37,44 The group assessment has shown
comparable clinical outcomes with individual assessment.50
There is no consensus within the pain field regarding optimal
duration of pain treatment groups. Long-duration groups in
Australia are up to 120 hours.5 Typically, such long-duration
groups are offered to smaller numbers of more highly selected
patients, often with compensable funding status. From a service
design perspective, the potentially greater improvement of
individuals undertaking a long-duration group is offset by the
restrictions in access that necessarily apply.
The duration of 21 hours over 6 weeks was based on clinician
and patient feedback obtained after core pain treatment groups
of varying durations that HIPS had run in the past. The rationale
for this included patient acceptability, effective utilization of
clinician time, and adequate time for participants to practice
active strategies and problem solve pain-related issues. TheHIPS
team attempts to reverse the passive passenger role, reinforced
through years of traditional health care interactions.8,11,30
Burke et al.5 define the duration of such a program to be low (,30
hours) compared with the Australian average of 68.6 hours. Further
research, including analysis of ePPOC data, will enable identification
of the “sweet spot” in optimizing the resources required to achieve
acceptable clinical results, recognizing that the ideal results to
resource ratio may vary across different clinical contexts.
Hunter Integrated Pain Service standardized group pathway is
an example of a triaging model of care. Although this study was
a cross-sectional study and not a cohort study, the decreased
number of patients attending the active treatment stage or final
step of group pathway suggests a process of funneling of patients.
Those patients most ready to change and needing further support
engage in active treatment.30,33,34,58 The resource-efficient design
of the model allows for prioritization of finite resources, honors
patient decision-making, and values clinician effort.
Low literacy is a wide-reaching problem in health care.2
Communication techniques and educational strategies tailored to
behavior change and low literacy are imbedded consistently and
deliberately throughout HIPS standardized group pathway. All
written material was designed for fifth to sixth grade readability,
with educational aids such as tick boxes and incorporating short
active sentences.10,17,45,59
Ongoing open line of telephone communication and support
between the service and patient/GP was designed to decrease
need for frequent in-person consults and also guarded against
therapeutic relapse.
4.1. Limitations
There are a number of study limitations. First, the study did not
measure outcomes for those patients entering the nonstandard
individual pathway which precluded comparison of outcomes
with those entering the standardized pathway. Furthermore,
outcomes were only measured after Active Pain Treatment, the
third step in the standardized group pathway. Measuring
outcomes after each step of the pathway would have allowed
analysis of any additive therapeutic benefit for each step. Another
shortcoming of the study was the inability to differentiate between
those who leave the pathway positively because of good
therapeutic progress as opposed to those who disengage,
without such progress.
It is envisaged that this article will provide a foundation for
further exploring models of chronic pain management, with
comparison of outcomes from individual and group pathways as
an important focus. In addition, analysis of the impact of patient
complexity on progression through the group pathway may
inform more individually tailored programs. This would be
especially important for those identifying as indigenous, to ensure
cultural differences are respected and addressed appropriately.
5. Conclusions
Hunter Integrated Pain Service promotes short-duration groups
as the standard intervention for patients experiencing chronic
noncancer pain. This is efficient in terms of team resource
utilization and exposure of patients to evidence-based care.
Outcome data were noninferior for this standardized, sequenced,
short-duration group pathway, as compared to other services
whose data were typically based on more individualized
assessment and treatment and often, longer-duration groups.
This model has implications for other pain services that are
resource-limited and have lengthy waitlists.
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